For patients with HIV/AIDS who had a baseline CD4+ T-cell count of ≥350 cells/mL, the CD4+ T-cell count slightly increased or stabilized following treatment initiation, and there was no significant difference between the cART and TCM + cART groups. The gene discussed is CD4; the disease is AIDS.